Streptococcus pneumoniae is far and away the most common cause of invasive bacterial meningitis, which although rare is most prevalent in children and has a 20% fatality rate. As a result, meningitis is the attention-grabbing pneumococcal disease which makes headline news, but pneumococci are also a leading cause of respiratory morbidity and mortality in the developing world, as well as a common cause of glue-ear or otitis media. Now, growing antibiotic resistance in this organism is concentrating attention on the need for effective vaccination strategies to combat the infection.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze